Granisetron Transdermal Patch and Efavirenz: Interaction Details

Brand names
Efavirenz
Sustiva
Granisetron Transdermal Patch
SancusoSustolGranisol
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page

A close look at the Granisetron Transdermal Patch and Efavirenz interaction:

Share

Share this interaction

Granisetron Transdermal Patch

Brand names
  • Sancuso
  • Sustol
  • Granisol

What Happens When You Take Granisetron Transdermal Patch With Efavirenz

What can happen when they are taken together (rated Major)

An increased risk of

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Because the QT-prolonging effects of efavirenz may be with those of another drug that lengthens the or carries a recognized risk of , alternatives to efavirenz should be considered when such a combination would otherwise be used. A QT study enrolling 58 healthy subjects found that those with the *6/*6 genotype had a mean 2.25 times that of subjects with the CYP2B6 *1/*1 genotype, and their mean was prolonged by 8.7 milliseconds.1

The Granisetron Transdermal Patch and Efavirenz Interaction, Explained

Both efavirenz (Sustiva, an HIV medicine) and granisetron (the Sancuso patch, used to prevent nausea from chemotherapy) can affect your heart's electrical rhythm. Each can slightly lengthen what's called the . Together, they could add up and raise the chance of an irregular heartbeat. This concern is mostly theoretical, meaning it is based on how the drugs work rather than on many reported cases.

Don't stop or change either medicine on your own. Tell your pharmacist or doctor about everything you take. They may suggest a different option or check on you more closely. Let them know right away if you feel fainting, dizziness, or a racing or pounding heartbeat.

Mechanism: (). Efavirenz prolongs in a concentration-dependent way, and granisetron has a labeled QT effect.

  • Data: In a QT study (n=58), efavirenz was 2.25-fold higher in *6/*6 than in *1/*1 subjects, with a mean QTc prolongation of 8.7 ms in *6/*6.
  • Evidence: Theoretical for the combination. Onset unspecified. Severity on file: major.
  • Management: Consider alternatives to efavirenz when co-administered with other QT-prolonging drugs. If the combination is needed, consider baseline and follow-up , electrolyte (K, Mg) correction, and review of other QT-prolonging agents. Consider CYP2B6 poor-metabolizer status as a risk factor.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Granisetron Transdermal Patch and Efavirenz Interact

The likely mechanism

In short: Granisetron transdermal patch and efavirenz both lengthen the QT interval, a measure of the heart’s rhythm, so taken together the effect can add up.
How Drug Interactions Work See this kind of interaction drawn out, step by step, in “When Effects Add Up or Cancel Out”, one chapter of our one-minute explainer. See how it works 

How to Manage the Granisetron Transdermal Patch and Efavirenz Interaction

Your care team can manage this, and the documented approach is to consider alternatives to efavirenz when it is used with another drug that affects the .

  • Keep taking both medicines as prescribed unless your prescriber tells you otherwise.
  • Ask your pharmacist or prescriber whether a different option makes sense for you.
  • Your team may monitor you more closely, and your dose may need to be individualized.
  • Share a full list of your medicines, including over-the-counter products and supplements.
  • Report fainting, dizziness, or palpitations promptly.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Granisetron Transdermal Patch or Efavirenz need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: SUSTIVA oral capsules, oral tablets, efavirenz oral capsules, oral tablets

    A QT study in healthy subjects (N=58) that was enriched for polymorphisms found a positive association between efavirenz concentration and . After efavirenz 600 mg/day was given for 14 days, the mean in subjects with the CYP2B6 *6/*6 genotype was 2.25 times the mean Cmax in subjects with the CYP2B6 *1/*1 genotype, and the mean prolongation in subjects with the CYP2B6 *6/*6 genotype was 8.7 milliseconds.1

Granisetron Transdermal Patch and Efavirenz: Common Questions

How serious is the Granisetron Transdermal Patch and Efavirenz interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Granisetron Transdermal Patch and Efavirenz interaction managed?

Your care team can manage this, and the documented approach is to consider alternatives to efavirenz when it is used with another drug that affects the . Keep taking both medicines as prescribed unless your prescriber tells you otherwise. Ask your pharmacist or prescriber whether a different option makes sense for you. Your team may monitor you more closely, and your dose may need to be… Management is individual — always follow your own care team's guidance.

Is there an alternative to taking Granisetron Transdermal Patch with Efavirenz?

Your care team can manage this, and the documented approach is to consider alternatives to efavirenz when it is used with another drug that affects the .

Only your prescriber can decide whether a change fits you, so talk with them before changing either medicine.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "theoretical". Expected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

Ask About the Granisetron Transdermal Patch and Efavirenz Interaction

Ask in your own words about taking Granisetron Transdermal Patch and Efavirenz together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: SUSTIVA(R) oral capsules, oral tablets, efavirenz oral capsules, oral tablets. Bristol-Myers Squibb Company (per FDA), Princeton, NJ, 2023. DailyMed
Was this write-up helpful?

Other Serious Interactions of Granisetron Transdermal Patch and Efavirenz

Also serious with Efavirenz

Also serious with Granisetron Transdermal Patch

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Efavirenz

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study. This interaction.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.